- Home
- CIVI vs VCYT Comparison
CIVI vs VCYT Comparison
Compare CIVI & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIVI
- VCYT
- Stock Information
- Founded
- CIVI 1999
- VCYT 2006
- Country
- CIVI United States
- VCYT United States
- Employees
- CIVI N/A
- VCYT N/A
- Industry
- CIVI Oil & Gas Production
- VCYT Medical Specialities
- Sector
- CIVI Energy
- VCYT Health Care
- Exchange
- CIVI Nasdaq
- VCYT Nasdaq
- Market Cap
- CIVI 2.6B
- VCYT 2.9B
- IPO Year
- CIVI 2011
- VCYT 2013
- Fundamental
- Price
- CIVI $27.22
- VCYT $41.51
- Analyst Decision
- CIVI Hold
- VCYT Buy
- Analyst Count
- CIVI 13
- VCYT 10
- Target Price
- CIVI $42.10
- VCYT $42.40
- AVG Volume (30 Days)
- CIVI 2.2M
- VCYT 1.0M
- Earning Date
- CIVI 11-06-2025
- VCYT 11-04-2025
- Dividend Yield
- CIVI 7.33%
- VCYT N/A
- EPS Growth
- CIVI N/A
- VCYT N/A
- EPS
- CIVI 6.86
- VCYT 0.38
- Revenue
- CIVI $4,711,808,000.00
- VCYT $495,141,000.00
- Revenue This Year
- CIVI N/A
- VCYT $14.52
- Revenue Next Year
- CIVI N/A
- VCYT $9.90
- P/E Ratio
- CIVI $3.98
- VCYT $109.62
- Revenue Growth
- CIVI N/A
- VCYT 16.41
- 52 Week Low
- CIVI $22.79
- VCYT $22.61
- 52 Week High
- CIVI $55.35
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- CIVI 40.34
- VCYT 63.38
- Support Level
- CIVI $25.78
- VCYT $35.27
- Resistance Level
- CIVI $27.73
- VCYT $46.41
- Average True Range (ATR)
- CIVI 1.07
- VCYT 1.92
- MACD
- CIVI -0.05
- VCYT 0.62
- Stochastic Oscillator
- CIVI 37.25
- VCYT 59.02
About CIVI Civitas Resources Inc.
Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.